HR7091Referred to Committee

Expanding Veterans’ Access to Emerging Treatments Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-01-15
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Jack Bergman
Jack Bergman
Republican · MI · Representative
Votes with party: 98.5% (540 recorded votes)

Full profile: /officials/B001301

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Subcommittee on Health.

2026-02-02

Source: Congress.gov

Plain-English Summary

This bill would allow veterans to access newer medical treatments that haven't yet been fully approved by the FDA, giving them options beyond standard care for serious conditions. The change would affect veterans receiving care through the VA health system and could help them try experimental therapies that might otherwise be unavailable to them. The proposal is currently being reviewed by the congressional subcommittee that oversees veterans' health matters.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Affected Industries

Industries and interest groups with a stake in how this bill is resolved. Compare with each member's outside-money backers on their finance page.

DefenseVeterans

Why this matters: Look up any member who voted on this bill and check their finance page — do the industries listed above match the groups funding their campaigns? That's the kind of connection this tool is built to help you find.

Subjects

Armed Forces and National Security
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.